Saz-Leal, Paula http://orcid.org/0000-0002-6263-4709
Zamorano-Domínguez, Laura
Frías, Jesús http://orcid.org/0000-0001-9538-9677
Guerra, Pedro
Saura-Valls, Marc
Roca-Juanes, Ramón
Nebot-Troyano, Joaquín
García-Aguilar, Eva
Vilchez, Tatiana
Urso, Katia http://orcid.org/0000-0003-0141-4056
Funding for this research was provided by:
INIBSA GINECOLOGIA S.A.
ITF Research Pharma S.L.U.
Article History
Accepted: 27 April 2023
First Online: 15 June 2023
Declarations
:
: KU and LZ-D designed and performed the in vitro dissolution testing and analyzed data. JF, PG, MS-V, RR-J, and JN-T were involved in the design and performance of the pharmacokinetic study; PG analyzed the data and wrote the clinical study report. KU, LZ-D, TV, PS-L, and EG-A contributed to data interpretation and to the writing of the manuscript. All authors contributed to the interpretation of study data and critically reviewed and approved the final version of the manuscript.
: PS-L, LZ-D, EG-A, and TV are employees of ITF Research Pharma S.L.U. MS-V, RR-J and JN-T are employees of Inibsa Ginecologia S.A.
: This study was funded by ITF Research Pharma S.L.U. and Inibsa Ginecologia S.A.
: The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
: The study protocol was approved by the Independent Ethics Committee on Clinical Research of the Hospital Universitario La Paz in January 2014.
: All volunteers signed an informed consent prior to initiation of study procedures.
: All authors gave consent for publication.